单细胞分析揭示系统性硬化症相关间质性肺病中成纤维细胞异质性与肌成纤维细胞
该研究对4例健康对照和4例SSc-ILD患者的肺组织进行单细胞RNA测序,鉴定出健康肺中SPINT2hi、MFAP5hi和WIF1hi成纤维细胞亚群,并在SSc-ILD中发现了新的肌成纤维细胞群体。肌成纤维细胞在SSc-ILD中表型变化最大,强烈上调胶原蛋白和其他促纤维化基因,提示其分化和增殖是驱动纤维化的关键机制。
要点
- 健康肺存在SPINT2hi、MFAP5hi和WIF1hi成纤维细胞亚群。
- SSc-ILD中出现新的肌成纤维细胞群体,并有活跃增殖证据。
- 肌成纤维细胞在SSc-ILD中表型变化最大,上调胶原和促纤维化基因。
核心结论
- SSc-ILD和健康肺存在先前未认识的成纤维细胞异质性,肌成纤维细胞分化和增殖是驱动SSc-ILD纤维化的关键病理机制。
研究设计与样本
- 对13例 explanted 肺组织标本(56 196个细胞)进行基于液滴的单细胞RNA测序,并进行整合典型相关分析,标本来自4例健康对照和4例SSc-ILD患者。
- findings 通过额外样本的转录组和表位细胞索引测序(CITE-seq)确认。
主要发现
- 健康对照肺间充质细胞中鉴定出两个主要成纤维细胞群体(SPINT2hi和MFAP5hi)和一个次要群体(WIF1hi)。
- 对照和SSc-ILD间充质细胞联合分析鉴定出SPINT2hi、MFAP5hi、少量WIF1hi成纤维细胞以及一个新的大的肌成纤维细胞群体,并有活跃增殖的肌成纤维细胞证据。
- 肌成纤维细胞在SSc-ILD中发生最大的表型变化,强烈上调胶原蛋白和其他促纤维化基因的表达。
临床怎么用
- 研究结果提示肌成纤维细胞分化和增殖是SSc-ILD纤维化的关键机制,可能为针对肌成纤维细胞的治疗策略提供依据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Myofibroblasts are key effector cells in the extracellular matrix remodelling of systemic sclerosis-associated interstitial lung disease (SSc-ILD); however, the diversity of fibroblast populations present in the healthy and SSc-ILD lung is unknown and has prevented the specific study of the myofibroblast transcriptome. We sought to identify and define the transcriptomes of myofibroblasts and other mesenchymal cell populations in human healthy and SSc-ILD lungs to understand how alterations in fibroblast phenotypes lead to SSc-ILD fibrosis. METHODS: We performed droplet-based, single-cell RNA-sequencing with integrated canonical correlation analysis of 13 explanted lung tissue specimens (56 196 cells) from four healthy control and four patients with SSc-ILD, with findings confirmed by cellular indexing of transcriptomes and epitopes by sequencing in additional samples. RESULTS: Examination of gene expression in mesenchymal cells identified two major, SPINT2hi and MFAP5hi, and one minor, WIF1hi, fibroblast populations in the healthy control lung. Combined analysis of control and SSc-ILD mesenchymal cells identified SPINT2hi, MFAP5hi, few WIF1hi fibroblasts and a new large myofibroblast population with evidence of actively proliferating myofibroblasts. We compared differential gene expression between all SSc-ILD and control mesenchymal cell populations, as well as among the fibroblast subpopulations, showing that myofibroblasts undergo the greatest phenotypic changes in SSc-ILD and strongly upregulate expression of collagens and other profibrotic genes. CONCLUSIONS: Our results demonstrate previously unrecognised fibroblast heterogeneity in SSc-ILD and healthy lungs, and define multimodal transcriptome-phenotypes associated with these populations. Our data indicate that myofibroblast differentiation and proliferation are key pathological mechanisms driving fibrosis in SSc-ILD.
引用
- Valenzi E, Bulik M, Tabib T, et al. Single-cell analysis reveals fibroblast heterogeneity and myofibroblasts in systemic sclerosis-associated interstitial lung disease. Ann Rheum Dis. 2019. PMID: 31405848. doi:10.1136/annrheumdis-2018-214865
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。